- €2.37bn
- €2.28bn
- €3.65bn
Brief: Brenntag Becomes Pharmaceutical Applications Distributor For K+S
K+S falls as it cuts 2024 EBITDA guidance
Brief: K+S Q3 EBITDA At EUR 66 Mln VS Consensus At EUR 59.0 Mln
Brief: K+S Q3 Revenue EUR 866 Million Vs. IBES Estimate EUR 829.6 Million
Miner K+S quarterly earnings hit by lower potash prices
Top of the Street: European chemicals, DHL and DS Smith
Jefferies sees 'more constructive' diversified chemicals outlook in 2025, but challenges in agriculture
Europe Research Roundup: Air Liquide, Evonik Industries, Sodexo
Report says Belarus plans potash production cut, K+S shares rise
Archax Group to acquire Spanish broker
Analysis: Potash supply nears pre-war levels, pushing producers to cut output
K+S CEO Burkhard Lohr to retire, CFO takes over
Brief: K+S - Dr. Burkhard Lohr, Chairman Of Board Of Executive Directors, Has Decided Not To Extend His Mandate
Top of the Street: National Grid, Nestle, K+S, Publicis
Europe Research Roundup: AstraZeneca, Danske Bank, Johnson Matthey
JPM cuts K+S to 'neutral' on limited potash price upside
Europe's chemicals rise boosted by Chinese stimulus
Baader cuts K+S to 'sell' on potash market downturn
Europe Research Roundup: Argenx, Glencore, Volvo Car